Arcutis Biotherapeutics Inc
NASDAQ:ARQT

Watchlist Manager
Arcutis Biotherapeutics Inc Logo
Arcutis Biotherapeutics Inc
NASDAQ:ARQT
Watchlist
Price: 14.56 USD 4.52% Market Closed
Market Cap: 1.7B USD
Have any thoughts about
Arcutis Biotherapeutics Inc?
Write Note

Intrinsic Value

The intrinsic value of one ARQT stock under the Base Case scenario is 16.16 USD. Compared to the current market price of 14.56 USD, Arcutis Biotherapeutics Inc is Undervalued by 10%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ARQT Intrinsic Value
16.16 USD
Undervaluation 10%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Arcutis Biotherapeutics Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for ARQT cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about ARQT?
Bearish
Neutral
Bullish

Fundamental Analysis

14.56 USD
+4.52%
+4.52%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Arcutis Biotherapeutics Inc
US
Biotechnology
Market Cap
1.7B USD
IPO
Jan 31, 2020
Employees
147
United States of America
Market Cap
1.7B USD
Industry
Biotechnology
IPO
Jan 31, 2020
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Arcutis Biotherapeutics Inc

Provide an overview of the primary business activities
of Arcutis Biotherapeutics Inc.

What unique competitive advantages
does Arcutis Biotherapeutics Inc hold over its rivals?

What risks and challenges
does Arcutis Biotherapeutics Inc face in the near future?

Has there been any significant insider trading activity
in Arcutis Biotherapeutics Inc recently?

Summarize the latest earnings call
of Arcutis Biotherapeutics Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Arcutis Biotherapeutics Inc.

Provide P/S
for Arcutis Biotherapeutics Inc.

Provide P/E
for Arcutis Biotherapeutics Inc.

Provide P/OCF
for Arcutis Biotherapeutics Inc.

Provide P/FCFE
for Arcutis Biotherapeutics Inc.

Provide P/B
for Arcutis Biotherapeutics Inc.

Provide EV/S
for Arcutis Biotherapeutics Inc.

Provide EV/GP
for Arcutis Biotherapeutics Inc.

Provide EV/EBITDA
for Arcutis Biotherapeutics Inc.

Provide EV/EBIT
for Arcutis Biotherapeutics Inc.

Provide EV/OCF
for Arcutis Biotherapeutics Inc.

Provide EV/FCFF
for Arcutis Biotherapeutics Inc.

Provide EV/IC
for Arcutis Biotherapeutics Inc.

Show me price targets
for Arcutis Biotherapeutics Inc made by professional analysts.

What are the Revenue projections
for Arcutis Biotherapeutics Inc?

How accurate were the past Revenue estimates
for Arcutis Biotherapeutics Inc?

What are the Net Income projections
for Arcutis Biotherapeutics Inc?

How accurate were the past Net Income estimates
for Arcutis Biotherapeutics Inc?

What are the EPS projections
for Arcutis Biotherapeutics Inc?

How accurate were the past EPS estimates
for Arcutis Biotherapeutics Inc?

What are the EBIT projections
for Arcutis Biotherapeutics Inc?

How accurate were the past EBIT estimates
for Arcutis Biotherapeutics Inc?

Compare the revenue forecasts
for Arcutis Biotherapeutics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Arcutis Biotherapeutics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Arcutis Biotherapeutics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Arcutis Biotherapeutics Inc compared to its peers.

Compare the P/E ratios
of Arcutis Biotherapeutics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Arcutis Biotherapeutics Inc with its peers.

Analyze the financial leverage
of Arcutis Biotherapeutics Inc compared to its main competitors.

Show all profitability ratios
for Arcutis Biotherapeutics Inc.

Provide ROE
for Arcutis Biotherapeutics Inc.

Provide ROA
for Arcutis Biotherapeutics Inc.

Provide ROIC
for Arcutis Biotherapeutics Inc.

Provide ROCE
for Arcutis Biotherapeutics Inc.

Provide Gross Margin
for Arcutis Biotherapeutics Inc.

Provide Operating Margin
for Arcutis Biotherapeutics Inc.

Provide Net Margin
for Arcutis Biotherapeutics Inc.

Provide FCF Margin
for Arcutis Biotherapeutics Inc.

Show all solvency ratios
for Arcutis Biotherapeutics Inc.

Provide D/E Ratio
for Arcutis Biotherapeutics Inc.

Provide D/A Ratio
for Arcutis Biotherapeutics Inc.

Provide Interest Coverage Ratio
for Arcutis Biotherapeutics Inc.

Provide Altman Z-Score Ratio
for Arcutis Biotherapeutics Inc.

Provide Quick Ratio
for Arcutis Biotherapeutics Inc.

Provide Current Ratio
for Arcutis Biotherapeutics Inc.

Provide Cash Ratio
for Arcutis Biotherapeutics Inc.

What is the historical Revenue growth
over the last 5 years for Arcutis Biotherapeutics Inc?

What is the historical Net Income growth
over the last 5 years for Arcutis Biotherapeutics Inc?

What is the current Free Cash Flow
of Arcutis Biotherapeutics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Arcutis Biotherapeutics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Arcutis Biotherapeutics Inc

Current Assets 423.7m
Cash & Short-Term Investments 330.6m
Receivables 60.1m
Other Current Assets 33m
Non-Current Assets 13.6m
PP&E 3.2m
Intangibles 9.8m
Other Non-Current Assets 596k
Current Liabilities 172.4m
Accounts Payable 19.3m
Accrued Liabilities 53.6m
Other Current Liabilities 99.5m
Non-Current Liabilities 108.3m
Long-Term Debt 105.1m
Other Non-Current Liabilities 3.2m
Efficiency

Earnings Waterfall
Arcutis Biotherapeutics Inc

Revenue
138.7m USD
Cost of Revenue
-14.5m USD
Gross Profit
124.2m USD
Operating Expenses
-306.2m USD
Operating Income
-181.9m USD
Other Expenses
-13.6m USD
Net Income
-195.5m USD

Free Cash Flow Analysis
Arcutis Biotherapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

ARQT Profitability Score
Profitability Due Diligence

Arcutis Biotherapeutics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Positive Gross Profit
Exceptional 1-Year Revenue Growth
ROIC is Increasing
29/100
Profitability
Score

Arcutis Biotherapeutics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

ARQT Solvency Score
Solvency Due Diligence

Arcutis Biotherapeutics Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Short-Term Solvency
Low D/E
Long-Term Solvency
41/100
Solvency
Score

Arcutis Biotherapeutics Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ARQT Price Targets Summary
Arcutis Biotherapeutics Inc

Wall Street analysts forecast ARQT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARQT is 19.38 USD with a low forecast of 12.12 USD and a high forecast of 30.45 USD.

Lowest
Price Target
12.12 USD
17% Downside
Average
Price Target
19.38 USD
33% Upside
Highest
Price Target
30.45 USD
109% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for ARQT?

Click here to dive deeper.

Dividends

Arcutis Biotherapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ARQT is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

ARQT Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?
What is the Intrinsic Value of one ARQT stock?

The intrinsic value of one ARQT stock under the Base Case scenario is 16.16 USD.

Is ARQT stock undervalued or overvalued?

Compared to the current market price of 14.56 USD, Arcutis Biotherapeutics Inc is Undervalued by 10%.

Back to Top